Article

Felix Frueh, PhD, Speaks about the Health Economics of Personalized Medicine

In this video, Felix Frueh, PhD, President, Medco Research, discusses the advancements in personalized medicine over the past decade. Dr. Frueh also speaks about the clinical data that are being generated in order to prove to payers that this area of medicine is not only valuable but also affordable.

In this video, Felix Frueh, PhD, President, Medco Research, discusses the advancements in personalized medicine over the past decade. Dr. Frueh also speaks about the clinical data that are being generated in order to prove to payers that this area of medicine is not only valuable but also affordable.

This video was taken at CBI's 4th Annual Forum for Payers on Personalized Medicine conference in Washington, DC, on March 13, 2012.

Related Videos
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Douglas Flora, MD, FACCC
Molly Dean, MSW, Siftwell
Dr Xin Hu
Bridgette J. Picou, LVN, ACLPN, The Well Project
Priscilla Tsondai, MD, MPH, IAS/CIPHER
Mia Moore, PhD, Fred Hutch Cancer Center
rachel rohaidy
Steven Daniel Daveluy, MD, FAAD
Related Content
Sharon Hesterlee, PhD
March 13th 2025

Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025

Kyle Munz Sharon Hesterlee, PhD
Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025

Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH

Maggie L. Shaw Amy Colson, MD, MPH
New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care
February 11th 2025

Telemedicine’s Evolution and Expanding Access to Obesity, Specialty Care

Maggie L. Shaw George Jones
George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, expanding treatment beyond primary care.
Nilu Goonetilleke, PhD
March 10th 2025

HIVconsvX Vaccine Shows Safety, Immune Response in People on ART

Maggie L. Shaw Nilu Goonetilleke, PhD
This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Seemal R Desai, MD, FAAD.
March 4th 2025

An Elevated Member Experience, More Education, and Martha Stewart at the AAD 2025 Annual Meeting

Cameron Santoro Seemal R. Desai, MD, FAAD
Seemal R Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), emphasized his commitment to enhancing the upcoming 2025 annual meeting by introducing new events and expanding educational offerings to better serve and engage members.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo